What Did Maternal Hair Testing Show in a Tenerife Birth Cohort?
What does a cocaine-positive maternal hair sample at delivery say about the timing of exposure? A study of 347 mother–infant pairs at Hospital La Candelaria in Tenerife collected maternal scalp hair on the day of delivery. Investigators analyzed the three centimetres closest to the scalp, using that segment as an approximate record of the last trimester. Nine samples, or 2.6%, were positive for cocaine and/or benzoylecgonine.
The measured window
The researchers used an immunochemical screen followed by gas chromatography–mass spectrometry confirmation and quantitation of positive screens. Hair was cut at the posterior vertex. Their chosen proximal segment was three centimetres long because scalp hair grows at roughly one centimetre per month on average. That design chiefly addresses the late-pregnancy period represented by the collected segment. It cannot map an individual dose to a date or rule out exposure earlier in pregnancy outside the analyzed length.
What nine positives mean
Among the 347 maternal hair samples, nine contained cocaine and/or its principal metabolite benzoylecgonine by the study’s testing approach. The paper reports hair cocaine concentrations from 0.25 to 2.06 ng/mg and benzoylecgonine from 0.31 to 3.18 ng/mg in positive samples. These concentrations describe the tested hair. They do not directly measure fetal blood, infant tissue, maternal impairment at delivery, the exact frequency of use or the amount of a particular dose.
Limits of the birth-outcome comparison
The authors compared recorded obstetric and newborn characteristics. Newborns in the cocaine-positive group had lower average birth measures, but the reported differences in weight, length and head circumference were not statistically significant. The study included only nine cocaine-positive hair samples, came from a single hospital and did not compare maternal hair findings with meconium. The paper therefore does not establish that cocaine caused an outcome in a particular infant or supply a reliable individual risk estimate.
Practical reading: The finding is evidence of cocaine-related analytes in the sampled maternal hair segment among nine participants. The segment’s approximate time window and the study’s small positive group should remain visible whenever the result is discussed.
Source: Joya X, Gomez-Culebras M, Callejón A, et al. Cocaine use during pregnancy assessed by hair analysis in a Canary Islands cohort. BMC Pregnancy and Childbirth. 2012;12:2. doi:10.1186/1471-2393-12-2.



